"!-- -->
BRING ON THE PENGUINS
agency: GSW Worldwide
brand: Tamiflu
client: Roche
photo from left: Bruce Rooke, chief creative officer • Scott Tannenbaum, SVP, director of client services
An unbranded campaign can help move the mark, especially when you've got adorable computer-animated penguins from the movie Happy Feet as the stars. Roche and GSW licensed the cute critters from Warner Bros., and then used them to reach beyond Big Pharma's usual sphere of influence—right into the American multiplex, where they could target mothers and children at the same time during the flu season.
The execution of the pre-movie commercials wasn't easy: "There were a lot of moving pieces and parts to this," says GSW's Scott Tannenbaum. "We licensed music from Stevie Wonder. We had to get him to approve it, Roche to approve it, and Warner Bros. to approve it. It was complex but clearly well worth the effort." The result? Great traffic for the campaign Web site, FluFacts.com, and great sales for Tamiflu.
PREVIOUS AGENCY ‹‹ HOME ›› NEXT AGENCY
Fake Weight Loss Drugs: Growing Threat to Consumer Health
October 25th 2024In this episode of the Pharmaceutical Executive podcast, UpScriptHealth's Peter Ax, Founder and CEO, and George Jones, Chief Operations Officer, discuss the issue of counterfeit weight loss drugs, the potential health risks associated with them, increasing access to legitimate weight loss medications and more.
The Transformative Role of Medical Information in Customer Engagement
October 3rd 2024Stacey Fung, Head of Global Medical Information at Gilead Lifesciences, delves into the evolving role of Medical Information (MI) in the pharmaceutical industry. Covering key topics like patient engagement through omnichannel strategies, combating misinformation, and leveraging AI to enhance medical inquiries, the conversation with Stacey highlights MI's critical role in ensuring patient safety and supporting drug development. She also shares her professional journey and tidbits for early career professionals on professional development.
To Tackle the Plastic Waste Crisis in Pharma, Here’s Where to Start
October 30th 2024By demonstrating big advancements in recycling, pharma companies will be much more likely to attract shareholders and other investors, giving themselves a leg up in the competition to lead the biopharmaceutical industry well into the future.